FDA evaluated an application for IVD device for detection of influenza subtype H5 (Asian lineage), commonly known as avian flu. This device is properly classified into class II, it is a device for which the general controls by themselves are insufficient. This information collection is a measure that FDA has determined to be necessary to provide reasonable assurance of safety and effectiveness on Novel Influenza A Reagents.
This collection of information was approved under the emergency processing provisions of the Act. We are requesting a 3 year extension with change for this collection. As a result of a comment received, the toal burden hours was adjusted upward from 200 hours to 300 hours.
$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Saleda Perryman
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.